Bisoprolol

Generic name: Pronounced as (bis oh' proe lol)
Brand names
  • Zebeta®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 11/15/2017

Bisoprolol is used alone or in combination with other medications to treat high blood pressure. Bisoprolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve and decrease blood pressure.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Bisoprolol comes as a tablet to take by mouth. It is usually taken once a day. To help you remember to take bisoprolol, take it around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take bisoprolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of bisoprolol and gradually increase your dose.

Bisoprolol controls high blood pressure but does not cure it. It may take a few weeks before you feel the full benefit of bisoprolol. Continue to take bisoprolol even if you feel well. Do not stop taking bisoprolol without talking to your doctor. Suddenly stopping bisoprolol may cause angina (chest pain), heart attack, or irregular heartbeat. Your doctor will probably decrease your dose gradually.

Bisoprolol also is used sometimes to treat heart failure. Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking bisoprolol,

  • tell your doctor and pharmacist if you are allergic to bisoprolol, any other medications, or any ingredients in bisoprolol tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: calcium channel blockers such as diltiazem (Cardizem, Cartia XT, Dilacor XR, Tiazac, others) and verapamil (Calan, Covera-HS, Verelan, in Tarka); clonidine (Catapres, Kapvay, in Clorpres); medications for irregular heartbeat such as disopyramide (Norpace); other beta blockers; reserpine; and rifampin (Rifadin, Rimactane, in Rifamate, in Rifater). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma or other lung diseases; a slow heart rate; heart failure; heart, liver, or kidney disease; diabetes; severe allergies; circulation problems; or hyperthyroidism (an overactive thyroid gland).

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking bisoprolol, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking bisoprolol.

  • you should know that bisoprolol may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

  • you should know that if you have allergic reactions to different substances, your reactions may be worse while you are using bisoprolol, and your allergic reactions may not respond to the usual doses of injectable epinephrine.

If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Bisoprolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • excessive tiredness

    • vomiting

    • diarrhea

    • muscle aches

    • runny nose

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

    • shortness of breath

    • swelling of the hands, feet, ankles, or lower legs

    • unusual weight gain

    • fainting

  • Bisoprolol may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • swelling of the hands, feet, ankles, or lower legs

  • unusual weight gain

  • difficulty breathing or swallowing

  • dizziness

  • fainting

  • shakiness

  • sweating

  • confusion

  • blurred vision

  • headache

  • numbness or tingling of the mouth

  • weakness

  • extreme tiredness

  • sudden hunger

  • pale color

Keep all appointments with your doctor. Your blood pressure should be checked regularly to determine your response to bisoprolol. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Ziac® (containing Bisoprolol, Hydrochlorothiazide)

Drug Interaction
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Bisoprolol.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bisoprolol.
Aminophylline Aminophylline The risk or severity of adverse effects can be increased when Bisoprolol is combined with Aminophylline.
Calcium Carbonate Calcium Carbonate The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Calcium carbonate.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Candesartan.
Cilostazol Cilostazol Bisoprolol may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Bisoprolol can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Fenofibrate Fenofibrate Bisoprolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bisoprolol.
Magnesium Hydroxide Magnesium Hydroxide Bisoprolol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine Bisoprolol may increase the vasoconstricting activities of Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Bisoprolol.
Mycophenolate Mycophenolate Bisoprolol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan Naratriptan may decrease the antihypertensive activities of Bisoprolol.
Olsalazine Olsalazine Olsalazine may decrease the antihypertensive activities of Bisoprolol.
Paregoric Paregoric The serum concentration of Bisoprolol can be increased when it is combined with Morphine.
Penbutolol Penbutolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acebutolol.
Potassium Potassium Potassium may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Bisoprolol may decrease the excretion rate of Prednisone which could result in a higher serum level.
Ranitidine Ranitidine Bisoprolol may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The therapeutic efficacy of Reserpine can be increased when used in combination with Bisoprolol.
Rizatriptan Rizatriptan Bisoprolol may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Bisoprolol may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Bisoprolol can be increased when it is combined with Tacrolimus.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Bisoprolol.
Zolmitriptan Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Bisoprolol.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The serum concentration of Bisoprolol can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Bisoprolol may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Meperidine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Metoclopramide Injection Metoclopramide Injection Bisoprolol may increase the bradycardic activities of Metoclopramide.
Morphine Injection Morphine Injection The serum concentration of Bisoprolol can be increased when it is combined with Morphine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Bisoprolol may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cyclosporine Cyclosporine The serum concentration of Bisoprolol can be increased when it is combined with Cyclosporine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Enoxaparin.
Torsemide Torsemide Torasemide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine Olanzapine may increase the orthostatic hypotensive activities of Bisoprolol.
Dofetilide Dofetilide The therapeutic efficacy of Dofetilide can be increased when used in combination with Bisoprolol.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bisoprolol.
Meloxicam Meloxicam Meloxicam may decrease the antihypertensive activities of Bisoprolol.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Telmisartan Telmisartan The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Telmisartan.
Temozolomide Temozolomide Bisoprolol may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Bisoprolol may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Bisoprolol.
Rivastigmine Rivastigmine Bisoprolol may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine Trimipramine may increase the orthostatic hypotensive activities of Bisoprolol.
Perindopril Perindopril Bisoprolol may increase the hypotensive activities of Perindopril.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Bisoprolol.
Sirolimus Sirolimus The serum concentration of Sirolimus can be increased when it is combined with Bisoprolol.
Dutasteride Dutasteride Dutasteride may decrease the antihypertensive activities of Bisoprolol.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Epinephrine can be decreased when used in combination with Bisoprolol.
Eplerenone Eplerenone Bisoprolol may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Bisoprolol.
Zonisamide Zonisamide The therapeutic efficacy of Zonisamide can be increased when used in combination with Bisoprolol.
Aripiprazole Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Bisoprolol.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Bisoprolol.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Almotriptan Almotriptan Bisoprolol may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan Eletriptan may decrease the antihypertensive activities of Bisoprolol.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Bisoprolol.
Vardenafil Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Bisoprolol.
Alfuzosin Alfuzosin Alfuzosin may increase the hypotensive activities of Bisoprolol.
Emtricitabine Emtricitabine Bisoprolol may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Bisoprolol may increase the bradycardic activities of Memantine.
Tegaserod Tegaserod The serum concentration of Tegaserod can be increased when it is combined with Bisoprolol.
Tadalafil Tadalafil Bisoprolol may increase the antihypertensive activities of Tadalafil.
Frovatriptan Frovatriptan Frovatriptan may decrease the antihypertensive activities of Bisoprolol.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Bisoprolol.
Protriptyline Protriptyline Protriptyline may decrease the antihypertensive activities of Bisoprolol.
Rifaximin Rifaximin The metabolism of Bisoprolol can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Bisoprolol is combined with Duloxetine.
Tinidazole Tinidazole Bisoprolol may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Bosentan may increase the hypotensive activities of Bisoprolol.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Ganciclovir Ganciclovir Bisoprolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Bisoprolol.
Ribavirin Ribavirin Bisoprolol may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin Solifenacin may decrease the antihypertensive activities of Bisoprolol.
Valganciclovir Valganciclovir Bisoprolol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Amphetamine.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Bisoprolol.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Bisoprolol.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Bisoprolol.
Ramelteon Ramelteon Bisoprolol may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the antihypertensive activities of Bisoprolol.
Pregabalin Pregabalin The therapeutic efficacy of Pregabalin can be increased when used in combination with Bisoprolol.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Bisoprolol.
Tipranavir Tipranavir The serum concentration of Tipranavir can be increased when it is combined with Bisoprolol.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Bisoprolol.
Ranolazine Ranolazine The serum concentration of Bisoprolol can be increased when it is combined with Ranolazine.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Bisoprolol.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bisoprolol.
Varenicline Varenicline The risk or severity of adverse effects can be increased when Bisoprolol is combined with Varenicline.
Albuterol Albuterol The therapeutic efficacy of Salbutamol can be decreased when used in combination with Bisoprolol.
Paliperidone Paliperidone The serum concentration of Paliperidone can be increased when it is combined with Bisoprolol.
Bortezomib Bortezomib The serum concentration of Bortezomib can be increased when it is combined with Bisoprolol.
Clofarabine Injection Clofarabine Injection Bisoprolol may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Bisoprolol.
Lubiprostone Lubiprostone Bisoprolol may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Posaconazole Posaconazole The serum concentration of Posaconazole can be increased when it is combined with Bisoprolol.
Primaquine Primaquine The risk or severity of QTc prolongation can be decreased when Primaquine is combined with Bisoprolol.
Rituximab Injection Rituximab Injection Bisoprolol may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Aliskiren.
Pemetrexed Injection Pemetrexed Injection Bisoprolol may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Lisdexamfetamine Lisdexamfetamine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Bisoprolol.
Sorafenib Sorafenib The serum concentration of Bisoprolol can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Bisoprolol.
Lapatinib Lapatinib The serum concentration of Bisoprolol can be increased when it is combined with Lapatinib.
Levocetirizine Levocetirizine Bisoprolol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Bisoprolol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The serum concentration of Dasatinib can be increased when it is combined with Bisoprolol.
Mexiletine Mexiletine The therapeutic efficacy of Mexiletine can be increased when used in combination with Bisoprolol.
Azacitidine Injection Azacitidine Injection Bisoprolol may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus Temsirolimus The serum concentration of Bisoprolol can be increased when it is combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Nilotinib Nilotinib The serum concentration of Nilotinib can be increased when it is combined with Bisoprolol.
Toremifene Toremifene The serum concentration of Bisoprolol can be increased when it is combined with Toremifene.
Budesonide Budesonide Bisoprolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Betaine Betaine Glycine betaine may increase the bradycardic activities of Bisoprolol.
Doripenem Injection Doripenem Injection Bisoprolol may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Bisoprolol may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The serum concentration of Bisoprolol can be increased when it is combined with Desvenlafaxine.
Cevimeline Cevimeline The risk or severity of adverse effects can be increased when Cevimeline is combined with Bisoprolol.
Nebivolol Nebivolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Bisoprolol.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Bisoprolol.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine.
Flecainide Flecainide The therapeutic efficacy of Flecainide can be increased when used in combination with Bisoprolol.
Certolizumab Injection Certolizumab Injection Bisoprolol may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Bisoprolol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Silodosin Silodosin The serum concentration of Silodosin can be increased when it is combined with Bisoprolol.
Midazolam Midazolam Bisoprolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Milnacipran Milnacipran The serum concentration of Bisoprolol can be increased when it is combined with Milnacipran.
Plerixafor Injection Plerixafor Injection Bisoprolol may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Bisoprolol.
Fesoterodine Fesoterodine Bisoprolol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Betaxolol.
Iloperidone Iloperidone Bisoprolol may increase the orthostatic hypotensive activities of Iloperidone.
Prasugrel Prasugrel Bisoprolol may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide Bisoprolol may increase the bradycardic activities of Lacosamide.
Everolimus Everolimus The serum concentration of Everolimus can be increased when it is combined with Bisoprolol.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Bisoprolol.
Dronedarone Dronedarone Bisoprolol may increase the bradycardic activities of Dronedarone.
Pralatrexate Injection Pralatrexate Injection Bisoprolol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Bisoprolol.
Telavancin Injection Telavancin Injection Bisoprolol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Bisoprolol.
Topotecan Topotecan The serum concentration of Topotecan can be increased when it is combined with Bisoprolol.
Pazopanib Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Bisoprolol.
Asenapine Asenapine Bisoprolol may increase the orthostatic hypotensive activities of Asenapine.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Bisoprolol.
Dalfampridine Dalfampridine Bisoprolol may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Bisoprolol may increase the bradycardic activities of Fingolimod.
Cabazitaxel Injection Cabazitaxel Injection The serum concentration of Cabazitaxel can be increased when it is combined with Bisoprolol.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Lurasidone Lurasidone Lurasidone may decrease the antihypertensive activities of Bisoprolol.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Vilazodone Vilazodone Vilazodone may decrease the antihypertensive activities of Bisoprolol.
Ipilimumab Injection Ipilimumab Injection Bisoprolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Bisoprolol.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Azilsartan medoxomil.
Roflumilast Roflumilast Bisoprolol may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Bisoprolol.
Telaprevir Telaprevir The serum concentration of Glecaprevir can be increased when it is combined with Bisoprolol.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Bisoprolol.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Bisoprolol.
Ticagrelor Ticagrelor The serum concentration of Ticagrelor can be increased when it is combined with Bisoprolol.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Bisoprolol.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Bisoprolol.
Vandetanib Vandetanib The serum concentration of Bisoprolol can be increased when it is combined with Vandetanib.
Clobazam Clobazam The serum concentration of Bisoprolol can be increased when it is combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Bisoprolol can be increased when it is combined with Vemurafenib.
Ivacaftor Ivacaftor The serum concentration of Bisoprolol can be increased when it is combined with Ivacaftor.
Deferiprone Deferiprone Bisoprolol may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The serum concentration of Axitinib can be increased when it is combined with Bisoprolol.
Crizotinib Crizotinib The serum concentration of Crizotinib can be increased when it is combined with Bisoprolol.
Cabergoline Cabergoline Bisoprolol may increase the vasoconstricting activities of Cabergoline.
Naloxone Injection Naloxone Injection Bisoprolol may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Bisoprolol.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Bisoprolol can be increased when it is combined with Carfilzomib.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Bisoprolol.
Enzalutamide Enzalutamide The serum concentration of Bisoprolol can be increased when it is combined with Enzalutamide.
Mirabegron Mirabegron The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bisoprolol.
Regorafenib Regorafenib Regorafenib may increase the bradycardic activities of Bisoprolol.
Bosutinib Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Bisoprolol.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Bisoprolol.
Teduglutide Injection Teduglutide Injection Bisoprolol may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Tofacitinib Tofacitinib Bisoprolol may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Bisoprolol.
Ponatinib Ponatinib The serum concentration of Bisoprolol can be increased when it is combined with Ponatinib.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Bisoprolol.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Trastuzumab emtansine can be increased when it is combined with Bisoprolol.
Apixaban Apixaban The serum concentration of Apixaban can be increased when it is combined with Bisoprolol.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bisoprolol.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be increased when it is combined with Bisoprolol.
Trametinib Trametinib Bisoprolol may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Bisoprolol.
Afatinib Afatinib The serum concentration of Bisoprolol can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The serum concentration of Bisoprolol can be increased when it is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Vortioxetine Vortioxetine Bisoprolol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Lomitapide Lomitapide The serum concentration of Lomitapide can be increased when it is combined with Bisoprolol.
Avanafil Avanafil Avanafil may increase the antihypertensive activities of Bisoprolol.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Bisoprolol.
Obinutuzumab Injection Obinutuzumab Injection Bisoprolol may increase the hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir The serum concentration of Simeprevir can be increased when it is combined with Bisoprolol.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Bisoprolol.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Bisoprolol.
Apremilast Apremilast Bisoprolol may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Bisoprolol.
Ceritinib Ceritinib Bisoprolol may increase the bradycardic activities of Ceritinib.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Bisoprolol.
Belinostat Injection Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Bisoprolol.
Idelalisib Idelalisib The serum concentration of Idelalisib can be increased when it is combined with Bisoprolol.
Testosterone Injection Testosterone Injection Bisoprolol may decrease the excretion rate of Testosterone which could result in a higher serum level.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Bisoprolol.
Vorapaxar Vorapaxar The serum concentration of Bisoprolol can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Bisoprolol can be increased when it is combined with Suvorexant.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Bisoprolol.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Bisoprolol.
Methamphetamine Methamphetamine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Metamfetamine.
Tasimelteon Tasimelteon Bisoprolol may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat Bisoprolol may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection Bisoprolol may increase the bradycardic activities of Lanreotide.
Nintedanib Nintedanib The serum concentration of Nintedanib can be increased when it is combined with Bisoprolol.
Risperidone Injection Risperidone Injection Bisoprolol may increase the hypotensive activities of Risperidone.
Palbociclib Palbociclib The serum concentration of Bisoprolol can be increased when it is combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Bisoprolol.
Lenvatinib Lenvatinib The serum concentration of Lenvatinib can be increased when it is combined with Bisoprolol.
Panobinostat Panobinostat The serum concentration of Panobinostat can be increased when it is combined with Bisoprolol.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Bisoprolol.
Haloperidol Injection Haloperidol Injection The serum concentration of Bisoprolol can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine Bisoprolol may increase the bradycardic activities of Ivabradine.
Amiloride Amiloride Amiloride may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Bisoprolol can be increased when it is combined with Isavuconazonium.
Macitentan Macitentan Bisoprolol may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin The serum concentration of Bisoprolol can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Bisoprolol can be increased when it is combined with Rolapitant.
Daclatasvir Daclatasvir The serum concentration of Bisoprolol can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole Bisoprolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection Ziprasidone may increase the antihypertensive activities of Bisoprolol.
Cariprazine Cariprazine Cariprazine may decrease the antihypertensive activities of Bisoprolol.
Penicillin G Procaine Injection Penicillin G Procaine Injection Bisoprolol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Bisoprolol.
Cobimetinib Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Bisoprolol.
Osimertinib Osimertinib The serum concentration of Bisoprolol can be increased when it is combined with Osimertinib.
Ixazomib Ixazomib Bisoprolol may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Rifapentine Rifapentine The metabolism of Bisoprolol can be increased when combined with Rifapentine.
Lesinurad Lesinurad Bisoprolol may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Brivaracetam Injection Brivaracetam Injection Bisoprolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The serum concentration of Venetoclax can be increased when it is combined with Bisoprolol.
Cobicistat Cobicistat The serum concentration of Bisoprolol can be increased when it is combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Bisoprolol.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Bisoprolol.
Furosemide Injection Furosemide Injection Bisoprolol may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The serum concentration of Rucaparib can be increased when it is combined with Bisoprolol.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Bisoprolol.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may increase the orthostatic hypotensive activities of Bisoprolol.
Deutetrabenazine Deutetrabenazine Bisoprolol may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Bisoprolol may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide Safinamide may increase the hypotensive activities of Bisoprolol.
Naldemedine Naldemedine Bisoprolol may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Neratinib Neratinib The serum concentration of Bisoprolol can be increased when it is combined with Neratinib.
Enasidenib Enasidenib The serum concentration of Bisoprolol can be increased when it is combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Bisoprolol.
Benznidazole Benznidazole Bisoprolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Bisoprolol.
Delafloxacin Delafloxacin Bisoprolol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Bisoprolol.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Bisoprolol.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Bisoprolol.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Bisoprolol.
Apalutamide Apalutamide The serum concentration of Bisoprolol can be decreased when it is combined with Apalutamide.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Bisoprolol.
Avatrombopag Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Bisoprolol.
Baricitinib Baricitinib The serum concentration of Baricitinib can be increased when it is combined with Bisoprolol.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Bisoprolol.
Plazomicin Injection Plazomicin Injection Bisoprolol may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The serum concentration of Eliglustat can be increased when it is combined with Bisoprolol.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Bisoprolol.
Ivosidenib Ivosidenib The serum concentration of Bisoprolol can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Bisoprolol.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Bisoprolol.
Cannabidiol Cannabidiol Cannabidiol may decrease the antihypertensive activities of Bisoprolol.
Dacomitinib Dacomitinib The serum concentration of Dacomitinib can be increased when it is combined with Bisoprolol.
Duvelisib Duvelisib The serum concentration of Duvelisib can be increased when it is combined with Bisoprolol.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Bisoprolol.
Sarecycline Sarecycline The serum concentration of Bisoprolol can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol Bisoprolol may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Bisoprolol.
Gilteritinib Gilteritinib The serum concentration of Gilteritinib can be increased when it is combined with Bisoprolol.
Glasdegib Glasdegib The serum concentration of Glasdegib can be increased when it is combined with Bisoprolol.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Bisoprolol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bisoprolol.
Rifamycin Rifamycin The metabolism of Bisoprolol can be increased when combined with Rifamycin.
Prucalopride Prucalopride Bisoprolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Siponimod Siponimod Siponimod may decrease the antihypertensive activities of Bisoprolol.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Erdafitinib Erdafitinib The serum concentration of Bisoprolol can be increased when it is combined with Erdafitinib.
Solriamfetol Solriamfetol Bisoprolol may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Bisoprolol.
Entrectinib Entrectinib The serum concentration of Entrectinib can be increased when it is combined with Bisoprolol.
Istradefylline Istradefylline The serum concentration of Bisoprolol can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant The serum concentration of Bisoprolol can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Bisoprolol.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Bisoprolol.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Bisoprolol.
Lasmiditan Lasmiditan The serum concentration of Bisoprolol can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Bisoprolol.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Calcium acetate.
Tazemetostat Tazemetostat The serum concentration of Tazemetostat can be increased when it is combined with Bisoprolol.
Cenobamate Cenobamate The serum concentration of Bisoprolol can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Bisoprolol.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Bisoprolol.
Tucatinib Tucatinib Bisoprolol may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Bisoprolol.
Ripretinib Ripretinib The serum concentration of Bisoprolol can be increased when it is combined with Ripretinib.
Selpercatinib Selpercatinib Selpercatinib may decrease the antihypertensive activities of Bisoprolol.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Bisoprolol.
Fostemsavir Fostemsavir The serum concentration of Fostemsavir can be increased when it is combined with Bisoprolol.
Octreotide Octreotide The serum concentration of the active metabolites of Bisoprolol can be increased when Bisoprolol is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Bisoprolol.
Pralsetinib Pralsetinib The serum concentration of Bisoprolol can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Bisoprolol can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Bisoprolol.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Bisoprolol may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Bisoprolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Theophylline Theophylline The risk or severity of adverse effects can be increased when Bisoprolol is combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the antihypertensive activities of Bisoprolol.
Indomethacin Indomethacin Indomethacin may decrease the antihypertensive activities of Bisoprolol.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Bisoprolol.
Naproxen Naproxen Naproxen may decrease the antihypertensive activities of Bisoprolol.
Tolmetin Tolmetin Tolmetin may decrease the antihypertensive activities of Bisoprolol.
Sulindac Sulindac Sulindac may decrease the antihypertensive activities of Bisoprolol.
Trazodone Trazodone The serum concentration of Bisoprolol can be increased when it is combined with Trazodone.
Isotretinoin Isotretinoin Bisoprolol may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Phenobarbital Phenobarbital Phenobarbital may increase the hypotensive activities of Bisoprolol.
Metaxalone Metaxalone Bisoprolol may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Primidone Primidone Primidone may increase the hypotensive activities of Bisoprolol.
Methsuximide Methsuximide The therapeutic efficacy of Methsuximide can be increased when used in combination with Bisoprolol.
Diethylpropion Diethylpropion The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Diethylpropion.
Chlorpromazine Chlorpromazine The serum concentration of Bisoprolol can be increased when it is combined with Chlorpromazine.
Diazepam Diazepam Bisoprolol may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Bisoprolol may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Bisoprolol may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Bisoprolol may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine Bisoprolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Amantadine Amantadine Bisoprolol may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Bisoprolol.
Metaproterenol Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Bisoprolol.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the hypotensive activities of Bisoprolol.
Phenelzine Phenelzine Phenelzine may increase the hypotensive activities of Bisoprolol.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Bisoprolol.
Ergoloid Mesylates Ergoloid Mesylates Bisoprolol may increase the vasoconstricting activities of Ergoloid mesylate.
Tetracycline Tetracycline Bisoprolol may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Prochlorperazine Prochlorperazine The serum concentration of Bisoprolol can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine The serum concentration of Bisoprolol can be increased when it is combined with Thioridazine.
Trifluoperazine Trifluoperazine The serum concentration of Bisoprolol can be increased when it is combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Bisoprolol can be increased when used in combination with Sulfadiazine.
Methadone Methadone Methadone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Maprotiline Maprotiline Bisoprolol may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen Ibuprofen may decrease the antihypertensive activities of Bisoprolol.
Perphenazine Perphenazine The serum concentration of Bisoprolol can be increased when it is combined with Perphenazine.
Azathioprine Azathioprine Bisoprolol may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine Fluphenazine The serum concentration of Bisoprolol can be increased when it is combined with Fluphenazine.
Phentermine Phentermine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Bisoprolol.
Amoxapine Amoxapine Bisoprolol may increase the orthostatic hypotensive activities of Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Bisoprolol.
Mechlorethamine Mechlorethamine Mechlorethamine may increase the bradycardic activities of Bisoprolol.
Dactinomycin Dactinomycin The serum concentration of Dactinomycin can be increased when it is combined with Bisoprolol.
Pyridostigmine Pyridostigmine Pyridostigmine may increase the bradycardic activities of Bisoprolol.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Carbamazepine Carbamazepine Carbamazepine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Bisoprolol.
Clonidine Clonidine The risk or severity of adverse effects can be increased when Bisoprolol is combined with Clonidine.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Bisoprolol.
Hydralazine Hydralazine Bisoprolol may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Warfarin Warfarin Bisoprolol may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Bisoprolol may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The therapeutic efficacy of Loperamide can be increased when used in combination with Bisoprolol.
Promethazine Promethazine The serum concentration of Bisoprolol can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.
Nitrofurantoin Nitrofurantoin The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Nitrofurantoin.
Digoxin Digoxin The therapeutic efficacy of Digoxin can be increased when used in combination with Bisoprolol.
Loxapine Loxapine The serum concentration of Bisoprolol can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be decreased when Chloroquine is combined with Bisoprolol.
Quinine Quinine The therapeutic efficacy of Bisoprolol can be increased when used in combination with Quinine.
Ethosuximide Ethosuximide The therapeutic efficacy of Ethosuximide can be increased when used in combination with Bisoprolol.
Triamterene Triamterene Triamterene may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Bisoprolol.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital The serum concentration of Bisoprolol can be decreased when it is combined with Secobarbital.
Desipramine Desipramine Desipramine may decrease the antihypertensive activities of Bisoprolol.
Amitriptyline Amitriptyline Amitriptyline may increase the orthostatic hypotensive activities of Bisoprolol.
Imipramine Imipramine Imipramine may increase the orthostatic hypotensive activities of Bisoprolol.
Probenecid Probenecid Bisoprolol may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The therapeutic efficacy of Quinidine can be increased when used in combination with Bisoprolol.
Procainamide Procainamide The therapeutic efficacy of Procainamide can be increased when used in combination with Bisoprolol.
Isoniazid Isoniazid Bisoprolol may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Rifampin Rifampin The metabolism of Bisoprolol can be increased when combined with Rifampicin.
Disopyramide Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Bisoprolol.
Tamoxifen Tamoxifen The serum concentration of Bisoprolol can be increased when it is combined with Tamoxifen.
Butabarbital Butabarbital Butabarbital may increase the hypotensive activities of Bisoprolol.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Bisoprolol.
Liothyronine Liothyronine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Liothyronine.
Methimazole Methimazole The excretion of Methimazole can be decreased when combined with Bisoprolol.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Bisoprolol.
Glucagon Injection Glucagon Injection The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Glucagon.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Bisoprolol.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Bisoprolol.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Bisoprolol.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Bisoprolol can be increased when used in combination with Methyclothiazide.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of adverse effects can be increased when Bisoprolol is combined with Propranolol.
Minoxidil Minoxidil Minoxidil may increase the hypotensive activities of Bisoprolol.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline Nortriptyline may increase the orthostatic hypotensive activities of Bisoprolol.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Mercaptopurine Mercaptopurine The therapeutic efficacy of Mercaptopurine can be decreased when used in combination with Bisoprolol.
Phytonadione Phytonadione Bisoprolol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Nadolol Nadolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nadolol.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Clomiphene Clomiphene The serum concentration of Clomifene can be increased when it is combined with Bisoprolol.
Flavoxate Flavoxate Bisoprolol may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Bisoprolol.
Colchicine Colchicine The serum concentration of Colchicine can be increased when it is combined with Bisoprolol.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Dacarbazine Dacarbazine Bisoprolol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Ketoconazole Ketoconazole The serum concentration of Ketoconazole can be increased when it is combined with Bisoprolol.
Pyrantel Pyrantel Bisoprolol may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection Thiotepa may increase the bradycardic activities of Bisoprolol.
Vincristine Injection Vincristine Injection The serum concentration of Vincristine can be increased when it is combined with Bisoprolol.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may increase the bradycardic activities of Bisoprolol.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Bisoprolol.
Vinblastine Vinblastine The serum concentration of Bisoprolol can be increased when it is combined with Vinblastine.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bethanechol.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Metoprolol Metoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Metoprolol.
Aspirin Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.
Salsalate Salsalate Salsalate may decrease the antihypertensive activities of Bisoprolol.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Triazolam Triazolam Bisoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Bisoprolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine The therapeutic efficacy of Hyoscyamine can be increased when used in combination with Bisoprolol.
Propantheline Propantheline Bisoprolol may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Bisoprolol.
Diltiazem Diltiazem The therapeutic efficacy of Diltiazem can be increased when used in combination with Bisoprolol.
Nifedipine Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Bisoprolol is combined with Nifedipine.
Timolol Timolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Timolol.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Bisoprolol is combined with Verapamil.
Atenolol Atenolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Atenolol.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pindolol.
Cisplatin Injection Cisplatin Injection Bisoprolol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the antihypertensive activities of Bisoprolol.
Piroxicam Piroxicam Piroxicam may decrease the antihypertensive activities of Bisoprolol.
Bumetanide Bumetanide Bisoprolol may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide Etoposide The serum concentration of Bisoprolol can be increased when it is combined with Etoposide.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Bisoprolol.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Bisoprolol.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Bisoprolol.
Amoxicillin Amoxicillin Bisoprolol may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Bisoprolol may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Bisoprolol.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Bisoprolol.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Labetalol Labetalol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Labetalol.
Auranofin Auranofin Bisoprolol may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Gemfibrozil Gemfibrozil Bisoprolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bisoprolol.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the antihypertensive activities of Bisoprolol.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Enalapril is combined with Bisoprolol.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Bisoprolol.
Amiodarone Amiodarone The therapeutic efficacy of Amiodarone can be increased when used in combination with Bisoprolol.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the antihypertensive activities of Bisoprolol.
Diclofenac Diclofenac Diclofenac may decrease the antihypertensive activities of Bisoprolol.
Fluoxetine Fluoxetine The serum concentration of Bisoprolol can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The therapeutic efficacy of Nimodipine can be increased when used in combination with Bisoprolol.
Clozapine Clozapine Clozapine may increase the orthostatic hypotensive activities of Bisoprolol.
Estazolam Estazolam Bisoprolol may decrease the excretion rate of Estazolam which could result in a higher serum level.
Didanosine Didanosine Bisoprolol may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Clarithromycin Clarithromycin The serum concentration of Clarithromycin can be increased when it is combined with Bisoprolol.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Bisoprolol.
Etodolac Etodolac Etodolac may decrease the antihypertensive activities of Bisoprolol.
Felodipine Felodipine The therapeutic efficacy of Felodipine can be increased when used in combination with Bisoprolol.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Bisoprolol.
Nabumetone Nabumetone Nabumetone may decrease the antihypertensive activities of Bisoprolol.
Pravastatin Pravastatin The serum concentration of Bisoprolol can be increased when it is combined with Pravastatin.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Quinapril.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Bisoprolol.
Simvastatin Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Bisoprolol.
Amlodipine Amlodipine The therapeutic efficacy of Amlodipine can be increased when used in combination with Bisoprolol.
Itraconazole Itraconazole The serum concentration of Itraconazole can be increased when it is combined with Bisoprolol.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the antihypertensive activities of Bisoprolol.
Sotalol Sotalol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Sotalol.
Doxazosin Doxazosin Bisoprolol may increase the orthostatic hypotensive activities of Doxazosin.
Terazosin Terazosin Bisoprolol may increase the orthostatic hypotensive activities of Terazosin.
Isradipine Isradipine The therapeutic efficacy of Isradipine can be increased when used in combination with Bisoprolol.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Nizatidine Nizatidine Nizatidine may increase the bradycardic activities of Bisoprolol.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Nefazodone Nefazodone The serum concentration of Bisoprolol can be increased when it is combined with Nefazodone.
Lamotrigine Lamotrigine The therapeutic efficacy of Lamotrigine can be increased when used in combination with Bisoprolol.
Losartan Losartan The therapeutic efficacy of Losartan can be increased when used in combination with Bisoprolol.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Moexipril.
Ifosfamide Injection Ifosfamide Injection Bisoprolol may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The therapeutic efficacy of Nicardipine can be increased when used in combination with Bisoprolol.
Bupropion Bupropion Bisoprolol may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Saquinavir Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Bisoprolol.
Metformin Metformin The therapeutic efficacy of Bisoprolol can be increased when used in combination with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Dalteparin.
Nisoldipine Nisoldipine The therapeutic efficacy of Nisoldipine can be increased when used in combination with Bisoprolol.
Lamivudine Lamivudine Bisoprolol may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Amifostine Injection Amifostine Injection Bisoprolol may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The therapeutic efficacy of Bisoprolol can be increased when used in combination with Acarbose.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Bisoprolol.
Gemcitabine Injection Gemcitabine Injection The serum concentration of Bisoprolol can be increased when it is combined with Gemcitabine.
Ritonavir Ritonavir The serum concentration of Bisoprolol can be increased when it is combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Meropenem Injection Meropenem Injection Bisoprolol may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Clomipramine may decrease the antihypertensive activities of Bisoprolol.
Fosfomycin Fosfomycin Bisoprolol may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine Mirtazapine may decrease the antihypertensive activities of Bisoprolol.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Bisoprolol.
Topiramate Topiramate Topiramate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Bisoprolol.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bisoprolol.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Donepezil Donepezil Donepezil may increase the bradycardic activities of Bisoprolol.
Fexofenadine Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Bisoprolol.
Carvedilol Carvedilol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carvedilol.
Nilutamide Nilutamide Bisoprolol may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Bisoprolol.
Sertraline Sertraline The serum concentration of Bisoprolol can be increased when it is combined with Sertraline.
Propafenone Propafenone The risk or severity of adverse effects can be increased when Bisoprolol is combined with Propafenone.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Irbesartan.
Tamsulosin Tamsulosin Bisoprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Bisoprolol.
Finasteride Finasteride Finasteride may decrease the antihypertensive activities of Bisoprolol.
Quetiapine Quetiapine Bisoprolol may increase the hypotensive activities of Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Paroxetine Paroxetine The serum concentration of Bisoprolol can be increased when it is combined with Paroxetine.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Capecitabine Capecitabine Bisoprolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Abacavir Abacavir Bisoprolol may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The serum concentration of Sildenafil can be increased when it is combined with Bisoprolol.
Pioglitazone Pioglitazone The therapeutic efficacy of Bisoprolol can be increased when used in combination with Pioglitazone.
Celecoxib Celecoxib Celecoxib may decrease the antihypertensive activities of Bisoprolol.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Bisoprolol can be increased when used in combination with Rosiglitazone.
Tolterodine Tolterodine Bisoprolol may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Bisoprolol.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the antihypertensive activities of Bisoprolol.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Bisoprolol.
Galantamine Galantamine Bisoprolol may increase the bradycardic activities of Galantamine.
Rabeprazole Rabeprazole Bisoprolol may decrease the excretion rate of Rabeprazole which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!